TH1902, a new docetaxel‐peptide conjugate for the treatment of sortilin‐positive triple‐negative breast cancer

Triple‐negative breast cancer (TNBC) is a heterogeneous subgroup of cancers which lacks the expression and/or amplification of targetable biomarkers (ie, estrogen receptor, progestrogen receptor, and human epidermal growth factor receptor 2), and is often associated with the worse disease‐specific o...

Descripción completa

Detalles Bibliográficos
Autores principales: Demeule, Michel, Charfi, Cyndia, Currie, Jean‐Christophe, Larocque, Alain, Zgheib, Alain, Kozelko, Sophie, Béliveau, Richard, Marsolais, Christian, Annabi, Borhane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486219/
https://www.ncbi.nlm.nih.gov/pubmed/34314556
http://dx.doi.org/10.1111/cas.15086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486219/
https://www.ncbi.nlm.nih.gov/pubmed/34314556
http://dx.doi.org/10.1111/cas.15086

Ejemplares similares